ArticleBMJ open2023

Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.

Francesca M Ponzini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.